Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Li Website

Luowei Li, Ph.D.

Selected Publications

1)  Yang D, Kedei N, Li L, Tao J, Velasquez JF, Michalowski AM, Tóth BI, Marincsák R, Varga A, Bíró T, Yuspa SH, Blumberg PM.
RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.
Cancer Res. 70: 7905-17, 2010.
[Journal]
2)  Li L, Shukla S, Lee A, Garfield SH, Maloney DJ, Ambudkar SV, Yuspa SH.
The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.
Cancer Res. 70: 4509-19, 2010.
[Journal]
3)  Park JE, Li L, Park J, Knecht R, Strebhardt K, Yuspa SH, Lee KS.
Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay.
Proc. Natl. Acad. Sci. U.S.A. 106: 1725-30, 2009.
[Journal]
4)  Suh KS, Mutoh M, Mutoh T, Li L, Ryscavage A, Crutchley JM, Dumont RA, Cheng C, Yuspa SH.
CLIC4 mediates and is required for Ca2+-induced keratinocyte differentiation.
J. Cell. Sci. 120: 2631-40, 2007.
[Journal]
5)  Stepp MA, Liu Y, Pal-Ghosh S, Jurjus RA, Tadvalkar G, Sekaran A, Losicco K, Jiang L, Larsen M, Li L, Yuspa SH.
Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1.
J. Cell. Sci. 120: 2851-63, 2007.
[Journal]
6)  Li L, Sampat K, Hu N, Zakari J, Yuspa SH.
Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes.
J. Biol. Chem. 281: 3237-43, 2006.
[Journal]
7)  Seong YS, Min C, Li L, Yang JY, Kim SY, Cao X, Kim K, Yuspa SH, Chung HH, Lee KS.
Characterization of a novel cyclin-dependent kinase 1 inhibitor, BMI-1026.
Cancer Res. 63: 7384-91, 2003.
[Journal]
8)  Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, Kazanietz MG.
Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
J. Biol. Chem. 278: 33753-62, 2003.
[Journal]
9)  Alt A, Ohba M, Li L, Gartsbein M, Belanger A, Denning MF, Kuroki T, Yuspa SH, Tennenbaum T.
Protein kinase Cdelta-mediated phosphorylation of alpha6beta4 is associated with reduced integrin localization to the hemidesmosome and decreased keratinocyte attachment.
Cancer Res. 61: 4591-8, 2001.
[Journal]
10)  Acs P, Beheshti M, Szállási Z, Li L, Yuspa SH, Blumberg PM.
Effect of a tyrosine 155 to phenylalanine mutation of protein kinase cdelta on the proliferative and tumorigenic properties of NIH 3T3 fibroblasts.
Carcinogenesis. 21: 887-91, 2000.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 10/25/2010.